nLife Therapeutics receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research
23 September 2014 | By nLife
The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development...